Healthcare Business News
Erez Vigodman, Teva Pharmaceuticals
Photo credit: Sivan Fara

Teva taps board member Vigodman as president and CEO

By Jaimy Lee
Posted: January 9, 2014 - 12:30 pm ET

Teva Pharmaceutical Industries named Erez Vigodman president and CEO, less than three months after Dr. Jeremy Levin resigned from the Jerusalem-based drugmaker.

Vigodman, 54, has served as a Teva board member since 2009 and currently is as president and CEO of Makhteshim Agan Industries, a Tel Aviv-based manufacturer of generic pesticides. His appointment is effective Feb. 11.

Advertisement | View Media Kit


Teva Chairman Dr. Phillip Frost said in October that the company and Levin had taken different views about the direction of the company, which led to Levin's resignation.

Follow Jaimy Lee on Twitter: @MHjlee

What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...



Switch to the new Modern Healthcare Daily News app

For the best experience of on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.